Polyamine Analogues of Propanediamine Series Inhibit Prostate Tumor Cell Growth and Activate the Polyamine Catabolic Pathway
Autor: | Abdullah Hilal, S. P. Syatkin, Roman I. Sokuyev, Anna Yu. Korshunova, Kristina Y. Sungrapova, Alexander A. Terentyev, M. L. Blagonravov, E.V. Neborak, Maria V. Ploskonos |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
Cancer Research Spermine oxidase Diamines 03 medical and health sciences chemistry.chemical_compound Prostate cancer 0302 clinical medicine Prostate Cell Line Tumor LNCaP Polyamines medicine Humans Cell Proliferation Oxidoreductases Acting on CH-NH Group Donors Biogenic Polyamines Prostatic Neoplasms Cancer General Medicine medicine.disease Enzyme Activation medicine.anatomical_structure Oncology chemistry 030220 oncology & carcinogenesis Cancer cell Cancer research Polyamine Polyamine oxidase Metabolic Networks and Pathways |
Zdroj: | Anticancer Research. 40:1437-1441 |
ISSN: | 1791-7530 0250-7005 |
DOI: | 10.21873/anticanres.14085 |
Popis: | Background/aim Polyamines are important for the growth of eukaryotic cells. At high levels, they promote proliferation, invasion and migration of tumour cells. Polyamine metabolism is an important new target for anticancer therapy. Some polyamine analogues can have an inhibitory effect on tumour cells. The aim of this study was to explore the potential of certain butylated derivatives of propanediamine for prostate cancer chemotherapy. Materials and methods Human prostate cancer cells, LNCaP, were used for the evaluation of the antiproliferative activity of polyamine analogs and their influence on spermine oxidase. Results Tetrabutyl propanediamine and two new polyamine analogues inhibited the growth of LNCaP cells. At the same time, a strong activation of spermine oxidase was observed. Conclusion The investigated compounds demonstrated their potential value in the therapy of human prostate cancer. Their effect might be attributed to the activation of the polyamine catabolic pathway. |
Databáze: | OpenAIRE |
Externí odkaz: |